Morocco Approves AstraZeneca-Oxford Vaccine

Morocco Approves AstraZeneca-Oxford Vaccine

Morocco validated on Wednesday a "temporary emergency authorization " for the vaccine against Covid-19 developed by the British laboratory AstraZeneca and the University of Oxford, according to an official document from the Ministry of Health published by the Moroccan press. The launch date for the vaccination campaign to immunize some 25 million adults free of charge has not yet been announced.

The Country Opts for "Covishield"

The AstraZeneca / Oxford vaccine, marketed under the name Covidshield, is authorized for 12 months and will be administered in two stages, with an interval of "four and 12 weeks " between the two doses, specifies the document from the Department of Health. The authorities announced ten days ago that they had ordered 66 million doses of coronavirus vaccines from Briton AstraZeneca and Chinese Sinopharm, specifying that the coronavirus vaccination preparations were "very advanced. "

Coronavirus vaccines, optional, must primarily target frontline staff in the health, security, and education sectors and vulnerable and elderly people, before spreading to the rest of the population. Computer software piloted by the Ministry of the Interior has been set up to register the people concerned and monitor their state of health.

Restrictions Continued in Morocco

Morocco, a country of 35 million inhabitants, has a total of more than 447,000 cases of contamination, including 7,618 deaths. A nighttime curfew has been in effect since December 21, and for three weeks, gatherings are prohibited, and restaurants, cafes, shops, and supermarkets close from 8:00 PM Restaurants in Casablanca, Marrakech, Agadir, and Tangier are entirely closed for the period. Since mid-March, several cities, including the tourist capital Marrakech, were already subject to corona virus restrictions under the state of health emergency in force.